Squarepoint’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.07M | Buy |
+64,154
| New | +$2.37M | ﹤0.01% | 2154 |
|
|
2025
Q4 | – | Sell |
-166,862
| Closed | -$5.73M | – | 4936 |
|
|
2025
Q3 | $5.73M | Sell |
166,862
-730,525
| -81% | -$21M | 0.01% | 1378 |
|
|
2025
Q2 | $24.3M | Buy |
897,387
+794,307
| +771% | +$23M | 0.03% | 682 |
|
|
2025
Q1 | $3.06M | Buy |
103,080
+97,104
| +1,625% | +$3.7M | ﹤0.01% | 1768 |
|
|
2024
Q4 | $237K | Sell |
5,976
-30,172
| -83% | -$1.14M | ﹤0.01% | 4343 |
|
|
2024
Q3 | $1.23M | Buy |
+36,148
| New | +$1.02M | ﹤0.01% | 2437 |
|
|
2024
Q2 | – | Sell |
-142,227
| Closed | -$3.15M | – | 4688 |
|
|
2024
Q1 | $3.15M | Buy |
142,227
+3,384
| +2% | +$82.6K | 0.01% | 1798 |
|
|
2023
Q4 | $3.82M | Buy |
138,843
+98,469
| +244% | +$2.38M | 0.01% | 1564 |
|
|
2023
Q3 | $902K | Buy |
+40,374
| New | +$1.04M | ﹤0.01% | 2402 |
|
|
2023
Q2 | – | Sell |
-127,331
| Closed | -$2.84M | – | 4046 |
|
|
2023
Q1 | $2.84M | Buy |
+127,331
| New | +$3.08M | 0.01% | 1200 |
|
|
2022
Q4 | – | Sell |
-64,217
| Closed | -$1.07M | – | 3631 |
|
|
2022
Q3 | $1.07M | Buy |
+64,217
| New | +$1.45M | 0.01% | 1727 |
|
|
2021
Q3 | – | Sell |
-14,329
| Closed | -$573K | – | 3457 |
|
|
2021
Q2 | $573K | Buy |
14,329
+7,223
| +102% | +$309K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $382K | Sell |
7,106
-13,584
| -66% | -$782K | ﹤0.01% | 2230 |
|
|
2020
Q4 | $1.01M | Buy |
20,690
+12,494
| +152% | +$579K | 0.01% | 1322 |
|
|
2020
Q3 | $266K | Sell |
8,196
-3,263
| -28% | -$104K | ﹤0.01% | 1896 |
|
|
2020
Q2 | $297K | Sell |
11,459
-4,930
| -30% | -$123K | ﹤0.01% | 1606 |
|
|
2020
Q1 | $398K | Sell |
16,389
-111,591
| -87% | -$2.81M | 0.01% | 1158 |
|
|
2019
Q4 | $3.57M | Buy |
127,980
+30,173
| +31% | +$781K | 0.02% | 619 |
|
|
2019
Q3 | $2.35M | Sell |
97,807
-5,593
| -5% | -$149K | 0.02% | 788 |
|
|
2019
Q2 | $2.95M | Sell |
103,400
-97,367
| -48% | -$2.43M | 0.03% | 636 |
|
|
2019
Q1 | $5.02M | Buy |
200,767
+88,626
| +79% | +$1.69M | 0.05% | 439 |
|
|
2018
Q4 | $1.41M | Buy |
112,141
+8,434
| +8% | +$99.7K | 0.02% | 801 |
|
|
2018
Q3 | $990K | Buy |
103,707
+53,684
| +107% | +$592K | 0.01% | 993 |
|
|
2018
Q2 | $467K | Buy |
50,023
+10,223
| +26% | +$71.9K | 0.01% | 1215 |
|
|
2018
Q1 | $221K | Sell |
39,800
-8,768
| -18% | -$54.3K | ﹤0.01% | 1455 |
|
|
2017
Q4 | $317K | Sell |
48,568
-1,132
| -2% | -$8.42K | 0.01% | 1461 |
|
|
2017
Q3 | $436K | Buy |
49,700
+34,600
| +229% | +$281K | 0.01% | 1025 |
|
|
2017
Q2 | $126K | Buy |
15,100
+2,479
| +20% | +$20.2K | ﹤0.01% | 1380 |
|
|
2017
Q1 | $116K | Buy |
+12,621
| New | +$103K | ﹤0.01% | 1390 |
|
Other funds holding VCYT
VPM
VCM
AIM
Squarepoint's VCYT Position: Q1 2026 in Review
Squarepoint opened a new position in Veracyte (VCYT) in Q1 2026: 64,154 shares worth $2.07M. The stake represents ﹤0.01% of the portfolio and ranks #2154 among its holdings. This is a return to the name: Squarepoint previously reported a position in VCYT as recently as Q3 2025.
Squarepoint first reported a position in VCYT in Q1 2017 and has held it in 29 quarters since. The position peaked at $24.3M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Squarepoint held 64,154 shares of Veracyte worth $2.07M as of Q1 2026.
- Veracyte was a new Squarepoint position in Q1 2026.
- Veracyte made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2154 holding.
- Squarepoint first reported a position in Veracyte in Q1 2017 and has held it in 29 quarters since.
- Squarepoint's Veracyte position peaked at $24.3M in Q2 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.